Search

everythinglearnresearchcommunity

for

Search:↓

Frontal fibrosing alopecia may affect nails and could be a type of lichen planus, treatable with certain medications.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

The document concludes that more research is needed to understand and treat Beard Alopecia Areata due to limited current knowledge and evidence.

The monkey's hair loss was due to an autoimmune disease, not genetics.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

Two plywood factory workers developed contact dermatitis from phenol-formaldehyde resin, a known allergen.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

UVA1-light therapy successfully treated a child's skin condition, mycosis fungoides.

Human prenatal skin develops an immune network early on that helps with skin formation and healing without scarring.

Understanding alopecia areata's patterns can improve future research and treatments.

Skin abnormalities can indicate immunodeficiency due to shared origins with the immune system.

Finasteride can cause a unique skin reaction on the penile shaft.

UV light helped human hair transplants survive in mice without broad immunosuppression.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

Talc in street cocaine can cause immune-reactive skin nodules where injected.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

Hair loss treatment caused more hair loss in a man.

The dog with an Alopecia Areata-like condition showed signs of an autoimmune disease and partially regrew hair without treatment, suggesting dogs could be models for human AA research.

A man developed a skin cancer called folliculotropic mycosis fungoides after a kidney transplant.

A woman developed alopecia after her second Pfizer vaccine but regrew her hair with treatment and had no issues after a booster shot.

A woman's hair loss, resembling an autoimmune condition, improved after treatment, but requires ongoing checks due to potential serious associations.

The conclusion is that a new method could improve the identification of autoimmune targets in alopecia areata, despite some limitations.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Understanding the genetics of alopecia areata could lead to better treatments.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

A young child with complete hair loss improved significantly with a combination of hair growth treatments and laser therapy.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

JAK inhibitors may help treat alopecia areata and promote hair regrowth.